Breast lumps differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 137: Line 137:
| align="center" style="background:#F5F5F5;" |No increased risk of [[malignancy]]
| align="center" style="background:#F5F5F5;" |No increased risk of [[malignancy]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Milk retention [[cysts]] with fluid collection among [[pregnant]] women and during breast-feeding
* Milk retention [[cysts]] with fluid collection among [[pregnant]] women and during [[breast-feeding]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* After ending [[lactation]], the [[cysts]] resolve
* After ending [[lactation]], the [[cysts]] resolve
Line 177: Line 177:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nonproliferative breast lesions
| align="center" style="background:#F5F5F5;" |[[Acute]] [[inflammation]] due to [[obstruction]] of the [[Montgomery's glands|Montgomery's gland]]
| align="center" style="background:#F5F5F5;" | Single cystic lesion in retroareolar area
| align="center" style="background:#F5F5F5;" | Single cystic lesion in retroareolar area
| align="center" style="background:#F5F5F5;" | [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | [[Ultrasound]]
Line 248: Line 248:
| align="center" style="background:#F5F5F5;" |No increased risk of [[malignancy]]
| align="center" style="background:#F5F5F5;" |No increased risk of [[malignancy]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Common among lactating women (first three months of breast feeding)
* Common among lactating women (first three months of [[breast-feeding]])
* Periductal [[mastitis]] among smokers and associated with [[squamous]] [[metaplasia]]
* Periductal [[mastitis]] among smokers and associated with [[squamous]] [[metaplasia]]
| align="center" style="background:#F5F5F5;" |Resolve after anti-biotic therapy/
| align="center" style="background:#F5F5F5;" |Resolve after anti-biotic therapy/
Line 267: Line 267:
| align="center" style="background:#F5F5F5;" |[[Breast]] [[parenchyma]] [[inflammation]]:
| align="center" style="background:#F5F5F5;" |[[Breast]] [[parenchyma]] [[inflammation]]:
* [[Acute]] [[mastitis]]: [[Staphylococcus]] [[infection]]  
* [[Acute]] [[mastitis]]: [[Staphylococcus]] [[infection]]  
* [[Granulomatous]] [[mastitis]]: [[Tuberculosis]] or [[sarcoidosis]] [[infection]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Ill-defined area with hyperechogenicity with inflamed fat lobules
* Ill-defined area with hyperechogenicity with inflamed fat lobules
Line 307: Line 308:
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |Hard, immobile, solitary, and irregular margin
| align="center" style="background:#F5F5F5;" |
* Hard  
* Immobile
* Solitary
* Irregular margin
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |Breast size changes
| align="center" style="background:#F5F5F5;" |
 
* Breast size changes
Nipple abnormality
* Nipple abnormality
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Molecular alteration in epithelial cells
* Molecular alteration in [[epithelial cells]]
* Ductal
* Ductal
* Lobular
* [[Lobular]]
* Ductal/lobular
* Ductal/lobular
* Mucinous
* [[Mucinous]]
* Tubular
* [[Tubular]]
* Medullary
* [[Medullary]]
* Papillary
* [[Papillary]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Mammography: Spiculated  soft tissue, mass microcalcification
* [[Mammography]]: Spiculated  soft tissue, mass [[microcalcification]]
* Ultrasound: Spiculated, hypoechoic lesion, shadowing, internal calcification
* [[Ultrasound]]: Spiculated, hypoechoic lesion, shadowing, internal [[calcification]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Ultrasound
* [[Ultrasound]]
* Mammography
* [[Mammography]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* HER2- positive or negative
* HER2- positive or negative
Line 334: Line 339:
* Progestrone receptor (PR)
* Progestrone receptor (PR)
|-
|-
! align="center" style="background:#DCDCDC;" |[[Ductal carcinoma in situ]] (DCIS)<ref name="pmid20071685">{{cite journal |vauthors=Virnig BA, Tuttle TM, Shamliyan T, Kane RL |title=Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes |journal=J. Natl. Cancer Inst. |volume=102 |issue=3 |pages=170–8 |date=February 2010 |pmid=20071685 |doi=10.1093/jnci/djp482 |url=}}</ref><ref name="pmid19001605">{{cite journal |vauthors=Brinton LA, Sherman ME, Carreon JD, Anderson WF |title=Recent trends in breast cancer among younger women in the United States |journal=J. Natl. Cancer Inst. |volume=100 |issue=22 |pages=1643–8 |date=November 2008 |pmid=19001605 |pmc=2720764 |doi=10.1093/jnci/djn344 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Ductal carcinoma in situ]] ([[DCIS]])<ref name="pmid20071685">{{cite journal |vauthors=Virnig BA, Tuttle TM, Shamliyan T, Kane RL |title=Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes |journal=J. Natl. Cancer Inst. |volume=102 |issue=3 |pages=170–8 |date=February 2010 |pmid=20071685 |doi=10.1093/jnci/djp482 |url=}}</ref><ref name="pmid19001605">{{cite journal |vauthors=Brinton LA, Sherman ME, Carreon JD, Anderson WF |title=Recent trends in breast cancer among younger women in the United States |journal=J. Natl. Cancer Inst. |volume=100 |issue=22 |pages=1643–8 |date=November 2008 |pmid=19001605 |pmc=2720764 |doi=10.1093/jnci/djn344 |url=}}</ref>
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Unknown
* Unknown
Line 344: Line 349:
* Increase risk with aging
* Increase risk with aging
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Positive family history
* Positive [[family history]]
* nulliparity
* nulliparity
* Obesity
* [[Obesity]]
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
Line 357: Line 362:
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Noninvasive breast cancer
* Noninvasive [[breast cancer]]
* Heterogenous group of neoplastic lesions
* Heterogenous group of [[neoplastic]] lesions
| align="center" style="background:#F5F5F5;" | Suspicious microclacifications
| align="center" style="background:#F5F5F5;" | Suspicious [[microcalcification]]
| align="center" style="background:#F5F5F5;" | Mammography
| align="center" style="background:#F5F5F5;" | [[Mammography]]
| align="center" style="background:#F5F5F5;" | Na
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |Microinvasive [[breast cancer]]<ref name="pmid23791403">{{cite journal |vauthors=Sue GR, Lannin DR, Killelea B, Chagpar AB |title=Predictors of microinvasion and its prognostic role in ductal carcinoma in situ |journal=Am. J. Surg. |volume=206 |issue=4 |pages=478–81 |date=October 2013 |pmid=23791403 |doi=10.1016/j.amjsurg.2013.01.039 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |Microinvasive [[breast cancer]]<ref name="pmid23791403">{{cite journal |vauthors=Sue GR, Lannin DR, Killelea B, Chagpar AB |title=Predictors of microinvasion and its prognostic role in ductal carcinoma in situ |journal=Am. J. Surg. |volume=206 |issue=4 |pages=478–81 |date=October 2013 |pmid=23791403 |doi=10.1016/j.amjsurg.2013.01.039 |url=}}</ref>
Line 370: Line 375:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Uncommon
* Uncommon
* Commonly referred to DCIS with microinvasion  
* Commonly referred to [[DCIS]] with microinvasion  
* Average age 50-60 years old
* Average age 50-60 years old
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Nulliparity
* Nulliparity
* Positive family history
* Positive [[family history]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
Line 385: Line 390:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Associated with high grade DCIS
| align="center" style="background:#F5F5F5;" |Associated with high grade [[DCIS]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* A mass with or without calcifications
* A mass with or without [[calcification]]
* stromal reaction
* [[stromal]] reaction
| align="center" style="background:#F5F5F5;" | Mammography
| align="center" style="background:#F5F5F5;" | [[Mammography]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
Line 395: Line 400:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Primary: Unknown
* Primary: Unknown
* Secondary: Radiotherapy
* Secondary: [[Radiotherapy]]
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 402: Line 407:
* Average age of between 45-50 years
* Average age of between 45-50 years
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Positive history of breast cancer
* Positive history of [[breast cancer]]
* Rapid increase in size
* Rapid increase in size
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 414: Line 419:
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Heterogeneous nonepithelial malignancies from connective tissue of breast
* Heterogeneous nonepithelial malignancies from [[connective tissue]] of breast
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Noncalcified oval mass Indistinct margins
* Noncalcified oval mass Indistinct margins
| align="center" style="background:#F5F5F5;" | Mammography
| align="center" style="background:#F5F5F5;" | [[Mammography]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
Line 424: Line 429:
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" | ±
| align="center" style="background:#F5F5F5;" | ±
| align="center" style="background:#F5F5F5;" |Most common in premenopausal women (40-50 years)  
| align="center" style="background:#F5F5F5;" |Most common in [[premenopausal]] women (40-50 years)  
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Represent 1% of breast tumors
* Represent 1% of breast tumors
Line 442: Line 447:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nonepithelial breast neoplasm with average size of 5 cm
| align="center" style="background:#F5F5F5;" |Nonepithelial breast [[neoplasm]] with average size of 5 cm
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Solid mass
* Solid mass
Line 448: Line 453:
* Well-circumscribed
* Well-circumscribed
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Ultrasound
* [[Ultrasound]]
* Mammography
* [[Mammography]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |Lymphoma<ref name="pmid10375092">{{cite journal |vauthors=Brogi E, Harris NL |title=Lymphomas of the breast: pathology and clinical behavior |journal=Semin. Oncol. |volume=26 |issue=3 |pages=357–64 |date=June 1999 |pmid=10375092 |doi= |url=}}</ref><ref name="pmid10859001">{{cite journal |vauthors=Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D |title=Primary breast lymphomas--a retrospective analysis of twelve cases |journal=Acta Oncol |volume=39 |issue=2 |pages=135–9 |date=2000 |pmid=10859001 |doi= |url=}}</ref>  
! align="center" style="background:#DCDCDC;" |[[Lymphoma]]<ref name="pmid10375092">{{cite journal |vauthors=Brogi E, Harris NL |title=Lymphomas of the breast: pathology and clinical behavior |journal=Semin. Oncol. |volume=26 |issue=3 |pages=357–64 |date=June 1999 |pmid=10375092 |doi= |url=}}</ref><ref name="pmid10859001">{{cite journal |vauthors=Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D |title=Primary breast lymphomas--a retrospective analysis of twelve cases |journal=Acta Oncol |volume=39 |issue=2 |pages=135–9 |date=2000 |pmid=10859001 |doi= |url=}}</ref>  
| align="center" style="background:#F5F5F5;" |Non-Hodgkin lymphoma
| align="center" style="background:#F5F5F5;" |[[Non-Hodgkin lymphoma]]
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 478: Line 483:
* Without calcification
* Without calcification
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Mammography
* [[Mammography]]
* Core biopsy
* Core biopsy
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |Duct ectasia<ref name="pmid6286199">{{cite journal |vauthors=Schwartz GF |title=Benign neoplasms and "inflammations" of the breast |journal=Clin Obstet Gynecol |volume=25 |issue=2 |pages=373–85 |date=June 1982 |pmid=6286199 |doi= |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Duct ectasia]]<ref name="pmid6286199">{{cite journal |vauthors=Schwartz GF |title=Benign neoplasms and "inflammations" of the breast |journal=Clin Obstet Gynecol |volume=25 |issue=2 |pages=373–85 |date=June 1982 |pmid=6286199 |doi= |url=}}</ref>
| align="center" style="background:#F5F5F5;" |Unknown
| align="center" style="background:#F5F5F5;" |Unknown
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |Common among perimenopausal women
| align="center" style="background:#F5F5F5;" |Common among [[perimenopausal]] women
| align="center" style="background:#F5F5F5;" |Usually resolve spontaneously
| align="center" style="background:#F5F5F5;" |Usually resolve spontaneously


Line 502: Line 507:
* Fluid-filled ducts
* Fluid-filled ducts
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Ultrasound
* [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
Line 512: Line 517:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Possibly benign ones
* Possibly benign ones
* Harbor areas of atypia or DCIS
* Harbor areas of [[atypia]] or [[DCIS]]
* Surgical excision is recommended
* Surgical [[excision]] is recommended
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
Line 528: Line 533:
* Well-defined
* Well-defined
* Solid nodule
* Solid nodule
| align="center" style="background:#F5F5F5;" | Core needle biopsy
| align="center" style="background:#F5F5F5;" | Core needle [[biopsy]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |Lipoma<ref name="pmid16720843">{{cite journal |vauthors=Guray M, Sahin AA |title=Benign breast diseases: classification, diagnosis, and management |journal=Oncologist |volume=11 |issue=5 |pages=435–49 |date=May 2006 |pmid=16720843 |doi=10.1634/theoncologist.11-5-435 |url=}}</ref>
! align="center" style="background:#DCDCDC;" |[[Lipoma]]<ref name="pmid16720843">{{cite journal |vauthors=Guray M, Sahin AA |title=Benign breast diseases: classification, diagnosis, and management |journal=Oncologist |volume=11 |issue=5 |pages=435–49 |date=May 2006 |pmid=16720843 |doi=10.1634/theoncologist.11-5-435 |url=}}</ref>
| align="center" style="background:#F5F5F5;" |Unknown
| align="center" style="background:#F5F5F5;" |Unknown
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 556: Line 561:
* Hypoechoic lesion
* Hypoechoic lesion
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Core needle biopsy
* Core needle [[biopsy]]
* excisional biopsy
* Excisional biopsy
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
Line 563: Line 568:
! align="center" style="background:#F5F5F5;" |Unknown
! align="center" style="background:#F5F5F5;" |Unknown
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |Small risk of malignancy
! align="center" style="background:#F5F5F5;" |Small risk of [[malignancy]]
! align="center" style="background:#F5F5F5;" |Result in repeating pain during mensturation  
! align="center" style="background:#F5F5F5;" |Result in repeating pain during mensturation  
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
* May present as a mass or incidental finding on mammogram
* May present as a mass or incidental finding on [[mammogram]]
* No treatment is needed
* No treatment is needed


Line 584: Line 589:
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
* Well-defined or irregular mass
* Well-defined or irregular mass
* Microocalcification
* [[Microcalcification]]
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
* Mammography
* [[Mammography]]
! align="center" style="background:#F5F5F5;" |NA
! align="center" style="background:#F5F5F5;" |NA
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
Line 596: Line 601:
! align="center" style="background:#F5F5F5;" | Common in reproductive age women
! align="center" style="background:#F5F5F5;" | Common in reproductive age women
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
* Benign stromal proliferation
* [[Benign]] stromal [[proliferation]]
* Stimulation of vascular lesion
* Stimulation of vascular lesion
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |+
Line 609: Line 614:
! align="center" style="background:#F5F5F5;" |Nl
! align="center" style="background:#F5F5F5;" |Nl
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
* Slit-like spaces between glandular units   
* Slit-like spaces between [[glandular]] units   
* Confused with mammary angiosarcoma
* Confused with mammary [[angiosarcoma]]
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
* Well-defined
* Well-defined
Line 616: Line 621:
* Noncalcified
* Noncalcified
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
* Ultrasound
* [[Ultrasound]]
* Mammography
* [[Mammography]]
! align="center" style="background:#F5F5F5;" |NA
! align="center" style="background:#F5F5F5;" |NA
|-
|-
! align="center" style="background:#DCDCDC;" |Mondor's disease<ref name="pmid11436415">{{cite journal| author=Becker L, McCurdy LI, Taves DH| title=Superficial thrombophlebitis of the breast (Mondor's disease). | journal=Can Assoc Radiol J | year= 2001 | volume= 52 | issue= 3 | pages= 193-5 | pmid=11436415 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11436415  }}</ref><ref name="pmid1562972">{{cite journal| author=Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A| title=Mondor's disease and breast cancer. | journal=Cancer | year= 1992 | volume= 69 | issue= 9 | pages= 2267-70 | pmid=1562972 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1562972  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Mondor's disease]]<ref name="pmid11436415">{{cite journal| author=Becker L, McCurdy LI, Taves DH| title=Superficial thrombophlebitis of the breast (Mondor's disease). | journal=Can Assoc Radiol J | year= 2001 | volume= 52 | issue= 3 | pages= 193-5 | pmid=11436415 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11436415  }}</ref><ref name="pmid1562972">{{cite journal| author=Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A| title=Mondor's disease and breast cancer. | journal=Cancer | year= 1992 | volume= 69 | issue= 9 | pages= 2267-70 | pmid=1562972 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1562972  }}</ref>
! align="center" style="background:#F5F5F5;" |Complication of:
! align="center" style="background:#F5F5F5;" |Complication of:
* Surgery
* [[Surgery]]
* Core biopsy
* Core [[biopsy]]
* Radiation treatment
* [[Radiation therapy]]
* Trauma
* [[Trauma]]


! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |+
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |–
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
* Uncommon benign disease
* Uncommon [[benign]] disease
* Occur on outer side of breast or under nipple  
* Occur on outer side of breast or under nipple  
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
Line 643: Line 648:
! align="center" style="background:#F5F5F5;" |NA
! align="center" style="background:#F5F5F5;" |NA
! align="center" style="background:#F5F5F5;" |Nl
! align="center" style="background:#F5F5F5;" |Nl
! align="center" style="background:#F5F5F5;" |Thrombophlebitis of superficial veins of the breast
! align="center" style="background:#F5F5F5;" |[[Thrombophlebitis]] of superficial veins of the breast
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
* Tubular anechoic structure  
* [[Tubular]] anechoic structure  
* Multiple narrowing areas
* Multiple narrowing areas
! align="center" style="background:#F5F5F5;" |
! align="center" style="background:#F5F5F5;" |
* Clinical examination
* Clinical examination
* Ultrasound
* [[Ultrasound]]
* Mammography
* [[Mammography]]
! align="center" style="background:#F5F5F5;" |NA
! align="center" style="background:#F5F5F5;" |NA
|-
|-
Line 672: Line 677:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
! align="center" style="background:#DCDCDC;" |Diabetic mastopathy<ref name="pmid11772912">{{cite journal| author=Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB| title="Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. | journal=Diabetes Care | year= 2002 | volume= 25 | issue= 1 | pages= 121-6 | pmid=11772912 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11772912  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Diabetic]] mastopathy<ref name="pmid11772912">{{cite journal| author=Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB| title="Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. | journal=Diabetes Care | year= 2002 | volume= 25 | issue= 1 | pages= 121-6 | pmid=11772912 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11772912  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Unknown
* Unknown
* Autoimmune reaction
* [[Autoimmune]] reaction
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Lymphocytic mastitis or mastopathy
* [[Lymphocytic]] [[mastitis]] or mastopathy


* Common among premenopausal women
* Common among [[premenopausal]] women
* Longstanding diabetes mellitus type 1
* Longstanding [[diabetes mellitus type 1]]


| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 698: Line 703:
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Dense keloid-like fibrosis  
* Dense keloid-like [[fibrosis]]
* Periductal, lobular, and perivascular lymphocytic infiltration
* Periductal, lobular, and perivascular [[lymphocytic]] [[Infiltration (medical)|infiltration]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Irregular mass
* Irregular mass
Line 705: Line 710:
* Dense lesion
* Dense lesion
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Ultrasound
* [[Ultrasound]]
* Core needle biopsy
* Core needle [[biopsy]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |Gynecomastia<ref name="pmid23397020">{{cite journal| author=Draghi F, Tarantino CC, Madonia L, Ferrozzi G| title=Ultrasonography of the male breast. | journal=J Ultrasound | year= 2011 | volume= 14 | issue= 3 | pages= 122-9 | pmid=23397020 | doi=10.1016/j.jus.2011.06.004 | pmc=3558246 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23397020  }}</ref><ref name="pmid17881754">{{cite journal| author=Braunstein GD| title=Clinical practice. Gynecomastia. | journal=N Engl J Med | year= 2007 | volume= 357 | issue= 12 | pages= 1229-37 | pmid=17881754 | doi=10.1056/NEJMcp070677 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17881754  }}</ref>
! align="center" style="background:#DCDCDC;" |Gynecomastia<ref name="pmid23397020">{{cite journal| author=Draghi F, Tarantino CC, Madonia L, Ferrozzi G| title=Ultrasonography of the male breast. | journal=J Ultrasound | year= 2011 | volume= 14 | issue= 3 | pages= 122-9 | pmid=23397020 | doi=10.1016/j.jus.2011.06.004 | pmc=3558246 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23397020  }}</ref><ref name="pmid17881754">{{cite journal| author=Braunstein GD| title=Clinical practice. Gynecomastia. | journal=N Engl J Med | year= 2007 | volume= 357 | issue= 12 | pages= 1229-37 | pmid=17881754 | doi=10.1056/NEJMcp070677 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17881754  }}</ref>
| align="center" style="background:#F5F5F5;" |Hormonal imbalance
| align="center" style="background:#F5F5F5;" |[[Hormonal]] imbalance
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |Benign breast tissue swelling among men and boys around puberty
| align="center" style="background:#F5F5F5;" |Benign breast tissue swelling among men and boys around [[puberty]]


| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Benign proliferation of the male breast glandular tissue  
* [[Benign]] [[proliferation]] of the male breast [[glandular tissue]]
* Usually underlying nipple mass
* Usually underlying nipple mass
* At least 0.5 cm
* At least 0.5 cm
Line 730: Line 735:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Glandular breast changes
| align="center" style="background:#F5F5F5;" |[[Glandular]] breast changes
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Nodular pattern
* [[Nodular]] pattern
* Dendritic pattern
* Dendritic pattern
* Diffuse glandular pattern
* Diffuse glandular pattern
| align="center" style="background:#F5F5F5;" | Ultrasound
| align="center" style="background:#F5F5F5;" | [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |Sarcoidosis<ref name="pmid11587103">{{cite journal| author=Lower EE, Hawkins HH, Baughman RP| title=Breast disease in sarcoidosis. | journal=Sarcoidosis Vasc Diffuse Lung Dis | year= 2001 | volume= 18 | issue= 3 | pages= 301-6 | pmid=11587103 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11587103  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]]<ref name="pmid11587103">{{cite journal| author=Lower EE, Hawkins HH, Baughman RP| title=Breast disease in sarcoidosis. | journal=Sarcoidosis Vasc Diffuse Lung Dis | year= 2001 | volume= 18 | issue= 3 | pages= 301-6 | pmid=11587103 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11587103  }}</ref>
| align="center" style="background:#F5F5F5;" |Systemic involvement in sarcoidosis
| align="center" style="background:#F5F5F5;" |Systemic involvement in [[sarcoidosis]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |Rare in patients with systemic involvement
| align="center" style="background:#F5F5F5;" |Rare in patients with systemic involvement
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Benin palpable mass
* Benign palpable mass
* May mimic malignancy feature
* May mimic [[malignancy]] feature
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
Line 756: Line 761:
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |NA
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |Idiopathic systemic granulomatous disorder
| align="center" style="background:#F5F5F5;" |[[Idiopathic]] [[systemic]] [[granulomatous]] disorder
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Irregular,  
* Irregular,  
Line 762: Line 767:
* Spiculated solid mass
* Spiculated solid mass
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
Biopsy
[[Biopsy]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|-
|-
! align="center" style="background:#DCDCDC;" |Fat necrosis<ref name="pmid9423681">{{cite journal| author=Soo MS, Kornguth PJ, Hertzberg BS| title=Fat necrosis in the breast: sonographic features. | journal=Radiology | year= 1998 | volume= 206 | issue= 1 | pages= 261-9 | pmid=9423681 | doi=10.1148/radiology.206.1.9423681 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9423681  }}</ref>
! align="center" style="background:#DCDCDC;" |[[Fat necrosis]]<ref name="pmid9423681">{{cite journal| author=Soo MS, Kornguth PJ, Hertzberg BS| title=Fat necrosis in the breast: sonographic features. | journal=Radiology | year= 1998 | volume= 206 | issue= 1 | pages= 261-9 | pmid=9423681 | doi=10.1148/radiology.206.1.9423681 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9423681  }}</ref>
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Breast trauma
* Breast [[trauma]]
* Surgical intervention
* Surgical intervention
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |Common among women  
| align="center" style="background:#F5F5F5;" |
 
* Common among women
May mimic malignancy features
* May mimic [[malignancy]] features
| align="center" style="background:#F5F5F5;" |Benign breast lumps develop after trauma/ surgery
| align="center" style="background:#F5F5F5;" |
 
* Benign [[breast lumps]] develop after [[trauma]]/ [[surgery]]
Suspicious lumps required biopsy
* Suspicious lumps required [[biopsy]]
 
* No [[excision]] in established diagnosis
No excision in established diagnosis
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
Line 793: Line 797:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Collections of liquefied fat
* Collections of liquefied fat
* Oil cysts
* Oil [[cysts]]
| align="center" style="background:#F5F5F5;" | Ultrasound
| align="center" style="background:#F5F5F5;" | [[Ultrasound]]
| align="center" style="background:#F5F5F5;" | NA
| align="center" style="background:#F5F5F5;" | NA
|}
|}

Revision as of 20:52, 18 January 2019

Breast lumps Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Breast lumps from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Breast lumps differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Breast lumps differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Breast lumps differential diagnosis

on Breast lumps differential diagnosis

Breast lumps differential diagnosis in the news

Blogs on Breast lumps differential diagnosis

Directions to Hospitals Treating Breast lumps

Risk calculators and risk factors for Breast lumps differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Breast lumps must be differentiated from other diseases such as malignancy, cysts, inflammation and non-inflammatory solid lumps. Breast symptoms such as nipple discharge and mastalgia require assessment as well.

Differentiating Breast lumps from other Diseases

Differential diagnosis of breast lumps include:

Diseases Etiology Benign Malignant Clinical manifestation Paraclinical findings Gold standard diagnosis Associated findings
Demography History Symptoms Signs Lab findings Histopathology Imaging
Mass Mastalgia Nipple discharge Breast exam Skin changes LAP Others
Fibroadenoma[1]
  • Unknown
+ + ±
  • Solitary,
  • well-defined
  • mobile mass
NA Nl Proliferative breast lesion without atypia
  • Well-defined
  • Solid mass
NA
Breast cyst[2] +
  • May resolve after aspiration
  • Further evaluation for not completely resolved masses
+ ±
  • Solitary
  • Cluster of small masses or an ill-defined mass
  • Smooth, firm, and frequently tender
NA Nl
  • Nonproliferative breast lesions
  • simple cyst: Well circumscribed, posterior acoustic enhancement without internal echoes
  • Complicated cyst: Homogenous low-level internal echoes due to without solid components
  • Complex cyst: thick walls greater than 0.5 mm with solid component
NA
Fibrocystic change[3] +
  • Unknown prevalence among adolescents
  • >50% in women of reproductive age
  • Become present before menses and improve during mensturation
+ + ±
  • Painful breast tissue
  • Tender, nodular swelling
NA Nl Nonproliferative breast lesions
  • Small cysts in mammary zone
  • Fibroglandular tissue around the mass
NA
Galactocele[4] Milk duct obstruction + No increased risk of malignancy + ± ± NA Nl Retention cyst resulting from lactiferous duct occlusion
  • Ultrasound
  • Mammography
NA
Cysts of montgomery[5] Obstruction of periareolar glands of montgomery + No increased risk of malignancy Most common in age of 10-20 years old
  • More than 80% resolve spontaneously
  • Drainage is essential in rare cases
+ ± ±
  • Asymptomatic subareolar mass
  • Drainage of clear to brownish fluid
± NA Nl Acute inflammation due to obstruction of the Montgomery's gland Single cystic lesion in retroareolar area Ultrasound NA
Hamartoma[6] Unknown + Coexisting malignancy can occur Common in women older than 35 years old ±
  • Soft breast lump
  • Breast enlargement without palpable mass
± NA Nl
  • Well-described
  • Discrete, solid, and encapsulated lesion
NA
Breast abscess[7] Complication of breast mastitis + No increased risk of malignancy
  • Complication of lactational mastitis in 14% of cases
  • Common among African American women, heavy smokers , and obese patients
Resolve after drainage/

anti-biotic therapy

+ + + Blood culture is required in severe infection Fluid collection Ultrasound NA
Mastitis[8][9] + No increased risk of malignancy Resolve after anti-biotic therapy/

drainage

± + ± + Leukocytosis Breast parenchyma inflammation:
  • Ill-defined area with hyperechogenicity with inflamed fat lobules
  • Skin thickening
Ultrasound NA
Diseases Etiology Benign Malignant Demography History Mass Pain Nipple discharge Breast exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Breast carcinoma[10][11][12] +
  • Most common diagnosed cancer among women
  • Leading cause of cancer death in women 40-49 years old
Positive family history + ±
  • Hard
  • Immobile
  • Solitary
  • Irregular margin
± ±
  • Breast size changes
  • Nipple abnormality
Nl
  • HER2- positive or negative
  • Estrogen receptor (ER)
  • Progestrone receptor (PR)
Ductal carcinoma in situ (DCIS)[13][14] +
  • Contain 25% of all breast cancers
  • Increase risk with aging
± ± May have normal physical exam NA Nl Suspicious microcalcification Mammography NA
Microinvasive breast cancer[15] Unknown

+
  • Uncommon
  • Commonly referred to DCIS with microinvasion
  • Average age 50-60 years old
+ ±
  • Solitary
  • firm palpable mass
± NA Nl Associated with high grade DCIS Mammography NA
Breast sarcoma[16] +
  • Rare type, < 1% of all breast malignancies
  • Average age of between 45-50 years
+ Well-defined, firm mass ± NA Nl
  • Noncalcified oval mass Indistinct margins
Mammography NA
Phyllodes tumor[17][18] Unknown ± ± Most common in premenopausal women (40-50 years)
  • Represent 1% of breast tumors
  • Grow aggressively
  • Classify in benign, borderline, and malignant groups
±
  • Smooth and multinodular
  • Well-defined
  • Firm mass
  • Mobile
NA Nl Nonepithelial breast neoplasm with average size of 5 cm
  • Solid mass
  • Hypoechoic
  • Well-circumscribed
NA
Lymphoma[19][20] Non-Hodgkin lymphoma +
  • Extremely rare ( 0.04%-0.5%)
  • Average age 55-60 years
  • Unilateral mass in older women
  • In childbearing women, bilateral and similar to inflammatory breast cancer, possibly having Burkitt lymphoma
+
  • Well-defined, firm mass
  • Multiple
± NA Nl

Diffuse B cell lymphomas

  • Nonspecific circumscribed masses
  • Without calcification
NA
Duct ectasia[21] Unknown + Common among perimenopausal women Usually resolve spontaneously ± ± ± Usually asymptomatic NA Nl Distention of subareolar ducts
  • Dilated milk ducts
  • Fluid-filled ducts
NA
Intraductal papilloma[22] Unknown + Common in women between 35-55 years old + ± ±
  • Solitary or multiple lesion
  • large lump near nipple
NA Nl Growth of papillary cell into a lumen
  • Well-defined
  • Solid nodule
Core needle biopsy NA
Lipoma[23] Unknown + Common between age of 40-60 years old
  • Benign tumors
  • May experience recurrence
+
  • Solitary
  • Mobile
  • Soft mass
NA Nl Solitary tumor of mature fat cells
  • Well-Circumscribed
  • Hypoechoic lesion
  • Core needle biopsy
  • Excisional biopsy
NA
Sclerosing adenosis[24][25] Unknown + Small risk of malignancy Result in repeating pain during mensturation
  • May present as a mass or incidental finding on mammogram
  • No treatment is needed
± +
  • Multiple lesion
  • Firm
  • Tender nodules
± NA Nl
  • Proliferative disease
NA
Pseudoangiomatous stromal hyperplasia[26][27] Unknown + Common in reproductive age women +
  • Solitary firm mass
  • Thickening
NA Nl
  • Well-defined
  • Solid mass
  • Noncalcified
NA
Mondor's disease[28][29] Complication of: +
  • Uncommon benign disease
  • Occur on outer side of breast or under nipple
  • Benign and self-limiting disease
  • Resolve after 4-6 weeks
+ + Thick and tender cord on breast skin + NA Nl Thrombophlebitis of superficial veins of the breast
  • Tubular anechoic structure
  • Multiple narrowing areas
NA
Diseases Etiology Benign Malignant Demography History Mass Pain Nipple discharge Breast exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Diabetic mastopathy[30] +
  • Suspicious breast mass
  • After diagnosis, excision is not required
+ Ill-defined mass

Immobile

NA Nl
  • Irregular mass
  • Hypoechoic
  • Dense lesion
NA
Gynecomastia[31][32] Hormonal imbalance + Benign breast tissue swelling among men and boys around puberty + ± ±
  • Unilateral or bilateral firm mass
  • Breast swelling
  • Rubbery mass
NA Nl Glandular breast changes
  • Nodular pattern
  • Dendritic pattern
  • Diffuse glandular pattern
Ultrasound NA
Sarcoidosis[33] Systemic involvement in sarcoidosis + Rare in patients with systemic involvement +
  • Firm mass
  • Hard mass
NA Nl Idiopathic systemic granulomatous disorder
  • Irregular,
  • Ill-defined,
  • Spiculated solid mass

Biopsy

NA
Fat necrosis[34]
  • Breast trauma
  • Surgical intervention
+ + ±
  • Hard or smooth mass
  • Solitary mass
  • Mobile
NA Nl Collections of liquefied fat
  • Collections of liquefied fat
  • Oil cysts
Ultrasound NA

References

  1. Pinto, Joana; Aguiar, Ana Teresa; Duarte, Hálio; Vilaverde, Filipa; Rodrigues, Ângelo; Krug, José Luís (2014). "Simple and Complex Fibroadenomas". Journal of Ultrasound in Medicine. 33 (3): 415–419. doi:10.7863/ultra.33.3.415. ISSN 0278-4297.
  2. Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V; et al. (2005). "Benign breast diseases". J Mammary Gland Biol Neoplasia. 10 (4): 325–35. doi:10.1007/s10911-006-9006-4. PMID 16900392.
  3. Templeman C, Hertweck SP (2000). "Breast disorders in the pediatric and adolescent patient". Obstet Gynecol Clin North Am. 27 (1): 19–34. PMID 10693180.
  4. Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P; et al. (2007). "Radiologic evaluation of breast disorders related to pregnancy and lactation". Radiographics. 27 Suppl 1: S101–24. doi:10.1148/rg.27si075505. PMID 18180221.
  5. De Silva NK, Brandt ML (2006). "Disorders of the breast in children and adolescents, Part 2: breast masses". J Pediatr Adolesc Gynecol. 19 (6): 415–8. doi:10.1016/j.jpag.2006.09.002. PMID 17174833.
  6. Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC; et al. (2002). "Hamartoma of the breast: a clinicopathological review". J Clin Pathol. 55 (12): 951–4. PMC 1769817. PMID 12461066.
  7. Dixon JM (2007). "Breast abscess". Br J Hosp Med (Lond). 68 (6): 315–20. doi:10.12968/hmed.2007.68.6.23574. PMID 17639835.
  8. Dixon JM, Ravisekar O, Chetty U, Anderson TJ (1996). "Periductal mastitis and duct ectasia: different conditions with different aetiologies". Br J Surg. 83 (6): 820–2. PMID 8696751.
  9. Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists (2007). "ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects". Obstet Gynecol. 109 (2 Pt 1): 479–80. PMID 17267864.
  10. Siegel RL, Miller KD, Jemal A (January 2018). "Cancer statistics, 2018". CA Cancer J Clin. 68 (1): 7–30. doi:10.3322/caac.21442. PMID 29313949.
  11. Li CI, Uribe DJ, Daling JR (October 2005). "Clinical characteristics of different histologic types of breast cancer". Br. J. Cancer. 93 (9): 1046–52. doi:10.1038/sj.bjc.6602787. PMC 2361680. PMID 16175185.
  12. Parise CA, Bauer KR, Brown MM, Caggiano V (2009). "Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004". Breast J. 15 (6): 593–602. doi:10.1111/j.1524-4741.2009.00822.x. PMID 19764994.
  13. Virnig BA, Tuttle TM, Shamliyan T, Kane RL (February 2010). "Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes". J. Natl. Cancer Inst. 102 (3): 170–8. doi:10.1093/jnci/djp482. PMID 20071685.
  14. Brinton LA, Sherman ME, Carreon JD, Anderson WF (November 2008). "Recent trends in breast cancer among younger women in the United States". J. Natl. Cancer Inst. 100 (22): 1643–8. doi:10.1093/jnci/djn344. PMC 2720764. PMID 19001605.
  15. Sue GR, Lannin DR, Killelea B, Chagpar AB (October 2013). "Predictors of microinvasion and its prognostic role in ductal carcinoma in situ". Am. J. Surg. 206 (4): 478–81. doi:10.1016/j.amjsurg.2013.01.039. PMID 23791403.
  16. Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT (April 2012). "Imaging features of primary breast sarcoma". AJR Am J Roentgenol. 198 (4): W386–93. doi:10.2214/AJR.11.7341. PMID 22451578.
  17. Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA (April 2000). "Phyllodes tumors of the breast: a review of 32 cases". Am Surg. 66 (4): 360–6. PMID 10776873.
  18. Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK (October 2000). "Primary treatment of cystosarcoma phyllodes of the breast". Cancer. 89 (7): 1502–11. PMID 11013364.
  19. Brogi E, Harris NL (June 1999). "Lymphomas of the breast: pathology and clinical behavior". Semin. Oncol. 26 (3): 357–64. PMID 10375092.
  20. Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D (2000). "Primary breast lymphomas--a retrospective analysis of twelve cases". Acta Oncol. 39 (2): 135–9. PMID 10859001.
  21. Schwartz GF (June 1982). "Benign neoplasms and "inflammations" of the breast". Clin Obstet Gynecol. 25 (2): 373–85. PMID 6286199.
  22. Wen X, Cheng W (January 2013). "Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors". Ann. Surg. Oncol. 20 (1): 94–101. doi:10.1245/s10434-012-2590-1. PMID 22878621.
  23. Guray M, Sahin AA (May 2006). "Benign breast diseases: classification, diagnosis, and management". Oncologist. 11 (5): 435–49. doi:10.1634/theoncologist.11-5-435. PMID 16720843.
  24. Jensen RA, Page DL, Dupont WD, Rogers LW (1989). "Invasive breast cancer risk in women with sclerosing adenosis". Cancer. 64 (10): 1977–83. PMID 2804888.
  25. Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004). "Lower-category benign breast disease and the risk of invasive breast cancer". J Natl Cancer Inst. 96 (8): 616–20. PMID 15100339.
  26. Celliers L, Wong DD, Bourke A (2010). "Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features". Clin Radiol. 65 (2): 145–9. doi:10.1016/j.crad.2009.10.003. PMID 20103437.
  27. Salvador R, Lirola JL, Domínguez R, López M, Risueño N (2004). "Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients". Breast. 13 (5): 431–5. doi:10.1016/j.breast.2003.10.011. PMID 15454202.
  28. Becker L, McCurdy LI, Taves DH (2001). "Superficial thrombophlebitis of the breast (Mondor's disease)". Can Assoc Radiol J. 52 (3): 193–5. PMID 11436415.
  29. Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A (1992). "Mondor's disease and breast cancer". Cancer. 69 (9): 2267–70. PMID 1562972.
  30. Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB (2002). ""Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes". Diabetes Care. 25 (1): 121–6. PMID 11772912.
  31. Draghi F, Tarantino CC, Madonia L, Ferrozzi G (2011). "Ultrasonography of the male breast". J Ultrasound. 14 (3): 122–9. doi:10.1016/j.jus.2011.06.004. PMC 3558246. PMID 23397020.
  32. Braunstein GD (2007). "Clinical practice. Gynecomastia". N Engl J Med. 357 (12): 1229–37. doi:10.1056/NEJMcp070677. PMID 17881754.
  33. Lower EE, Hawkins HH, Baughman RP (2001). "Breast disease in sarcoidosis". Sarcoidosis Vasc Diffuse Lung Dis. 18 (3): 301–6. PMID 11587103.
  34. Soo MS, Kornguth PJ, Hertzberg BS (1998). "Fat necrosis in the breast: sonographic features". Radiology. 206 (1): 261–9. doi:10.1148/radiology.206.1.9423681. PMID 9423681.


Template:WikiDoc Sources